LDN-214117, CAS [[1627503-67-6]]

Produktübersicht

• Artikelname: LDN-214117, CAS [[1627503-67-6]]
• Artikelnummer: MCE-HY-16712
• Hersteller Artikelnummer: HY-16712
• Alternativnummer: MCE-HY-16712-10MG,MCE-HY-16712-25MG,MCE-HY-16712-10MMX1ML,MCE-HY-16712-50MG,MCE-HY-16712-5MG,MCE-HY-16712-100MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

LDN-214117 is an orally active ALK2 inhibitor with well-tolerated and good brain penetration. LDN-214117 has a high selectivity and low cytotoxicity for ALK2 with an IC50 value of 24 nM. LDN-214117 also is a specific bone morphogenetic proteins (BMPs) signaling inhibitor and has relatively selective inhibition for BMP6 with an IC50 value of 100 nM. LDN-214117 can be used for the research of fibrodysplasia ossificans progressiva (FOP), diffuse intrinsic pontine glioma (DIPG) [1][2].

Produkteigenschaften

• Molekulargewicht: 419.52
• Reinheit: 99.54
• CAS Nummer: [1627503-67-6]
• Formel: C25H29N3O3
• Target-Kategorie: TGF-beta Receptor

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound